ABSTRACT
Introduction
Gene therapy has been a promising strategy for the treatment of malignancies. Combination gene therapy has the advantages of gene therapy, elevates the therapeutic efficacy and overcomes the shortcomings of single gene therapy 1, 2 . Combination gene therapy has become a direction in the development of gene therapy. In our previous animal studies 3, 4 , target gene was introduced to cancer cells which were then inoculated into animals for tumorigenesis. Our findings demonstrated that combination therapy with WTp53 gene and TK/GCV, CD/5-Fc could effectively treat colon cancer and prevent liver metastasis of colon cancer.
However, the therapeutic strategy is not practical. In clinical practice, it is impossible to introduce target gene into all cancer cells. In the present study, combination therapy of transcatheter arterial lipiodol chemoembolization with gene therapy was performed to treat liver cancer achieving favorable effectiveness.
Our findings bridge basic research and clinical application of interventional therapy and also provide a novel strategy for the clinical treatment of liver cancer and metastatic liver cancer.
Methods
The pCMV-p53 plasmids were kindly provided by the
Institute of Biochemistry and Molecular Biology in Shandong
University. PA317 cells and PA317/TK-CD were kindly provided by the Cancer Center of Qilu Hoapital of Shandong University.
A total of 50 New Zealand rabbits aged six to eight months weighing 2.0 to 2.5kg were purchased from the Academy artery catheter with fine needle, C arm DSA system and 64-slice CT (Siemens, Germany) were used in the present study.
Preparation of pCMV-p53 plasmid-liposome complex
The pCMV-p53 plasmids had expression of WTp53 and 
Establishment of liver cancer model in rabbits
The cancer cells were inoculated at the site near the groin of rabbit for tumorigenesis. Two weeks later, the tumor size was about 1 to 2 cm 3 . Then, the tumor was collected by surgery and the capsule was removed. The fish-like tumor tissues at the edge of tumor were cut into 1 to 2 mm 3 pieces followed by washing for further experiments 5 .
A total of 50 rabbits were used in the experiment. The animals were anesthetized and fixed. The skin of upper abdomen was prepared. An inverted V-shaped incision was made at the site below xiphoid with 1 to 2 cm in length. Laparotomy was performed and the xiphoid removed. Then, the liver was exposed.
The left middle lobe was clamped to block the local blood flow and exposed out of the abdomen and then fixed. The liver capsule was punctured and a hole was drilled with 3 to 5 mm in depth.
A tumor tissue was placed into the hole and the wound in the liver was dressed with a gelatin sponge followed by covering OB glue. When the glue solidified, the liver was placed back to the abdominal cavity and the abdominal wound was closed. The above procedures were performed under aseptic conditions. After surgery, animals received intramuscular injection of penicillin (800000 U) for three consecutive days.
Grouping and catheterization
Two weeks after surgery, further experiment started. Catheterization was performed through the femoral artery to the hepatic artery [6] [7] [8] . In brief, rabbits were anesthetized and fixed.
The skin of groin was prepared and a longitudinal incision was made at the groin along the femoral artery. The sheath of femoral artery was opened and femoral artery with 1 to 2 cm was separated.
A suture was used to wrap the distal femoral artery and then lifted to block the blood flow. A v-shaped incision was made in the anterior wall of femoral artery and the guiding wire was inserted. Then, the catheter sheath was inserted into femoral artery along the guiding wire with 4 cm catheter sheath in the artery. Then, the artery was ligated to fix the sheath. A 3F microcatheter was inserted along the sheath into the abdominal arteries following by angiography to find the proper hepatic artery. Super-selective catheterization was performed into the proper hepatic artery followed by angiography to confirm the liver parenchyma. Further angiography was carried out to confirm the right or left hepatic artery.
Treatments
Following catheterization, angiography was performed with Ultravist 300 as contrast in a digital subtraction device to confirm the target blood vessel. A 1.2 F microcatheter was inserted into the feeding artery of cancers ( Figure 1 ). Injection of drugs was performed under radiography.
In Group 1 (control group), normal saline (1 ml per animal) was injected through the feeding artery. In Group 2, ultraliquefied lipiodol (1 ml per animal) was injected through the feeding artery. In Group 3, ultra-liquefied lipiodol (1 ml per animal) and plasmids carrying p53 (0.1 ml per animal; 20 μg) were injected through the feeding artery. Studies have shown that the amount of p53 in a certain range was positively related to the transfection efficiency. When the amount of p53 was higher than 10 μg, the transfection efficiency remained stable. Thus, 20 μg of p53 was used in the present study. In Group 4, ultra-liquefied lipiodol (1 ml per animal) and concentrated supernatant from TK/CD (0.1 ml per animal; 1×10 9 PFU) were injected through the feeding artery.
In Group 5, ultra-liquefied lipiodol (1 ml per animal), concentrated supernatant from TK/CD (0.1 ml per animal; 1×10 9 PFU) and plasmids carrying p53 (0.1 ml per animal; 20 μg) were injected through the feeding artery.
Drug solution was administered with a microinjector.
Following injection, the catheter was flushed with 1 ml of normal saline with heparin. The catheter and its sheath were removed and the distal femoral artery was ligated followed by wound close.
Animals were intramuscularly treated with penicillin (800000 U)
for infection prophylaxis. Animals were put back to cages and housed in a specific pathogen free environment. On the second day of TK/CD treatment, intraperitoneal injection of GCV at 100 mg/ (kg·d) and 5-Fc at 500mg/(kg·d) was performed for consecutive 10 days.
Observations
Before and at ten days after interventional therapy, ultrasonography and CT were performed and the maximal (a) and minimal (b) diameters were measured followed by calculation of tumor volume (V=ab 2 /2) and tumor growth rate (volume after treatment / volume before treatment). At 8 weeks after interventional therapy, rabbits were sacrificed by cervical dislocation. Rabbits naturally died were also processed for observations. Pathological examination was carried out and the survival time was determined.
Statistical analysis
Statistical analysis was performed with SPSS version 
Results

Preparation of pCMV-p53 plasmid-liposome complex
The amplification, extraction and purification of pCMV-p53 plasmids were smooth. Agarose gel electrophoresis revealed a 4.7-kb band. Spectrophotometry showed the A260 and A280 were 1.28 and 0.70, respectively. The DNA content was 3.2 μg/μl and its purity was 1.83. Then, pCMV-p53 plasmids were embedded in Lipofectamine TM 2000 to prepare the pCMV-p53
plasmid -liposome complex, the concentration of which was 200 μg/ml.
Preparation of concentrated supernatant of TK-CD retrovirus
PA317 cells and PA317/TK-CD cells were successfully resuscitated. The concentration of G418 for screening PA317/TK-CD cells was 400 μg/ml. At two weeks after screening with G418, purified PA317/TK-CD cells were harvested followed by culture, passaging and frozen storage. A total of 20 ml of virus supernatant was collected and 2 ml of concentrated supernatant obtained. The titer of concentrated virus supernatant was 10 10 PFU/ml.
Tumor volume and tumor growth rate
There was no marked difference in tumor volume among five groups (p>0.05). At ten days after interventional therapy, the tumor volume was compared among five groups with analysis of variance and Least Significant Difference (LSD) test. Results showed significant difference in tumor volume (p<0.05) among five groups. These findings suggest different treatment can inhibit the tumor growth, which was the most obvious in the Group 5( Table 1) . 
Survival time
In the control group, rabbits died consecutively at 24 to 40 days after interventional therapy. In four treatment groups, a total of 13 rabbits died in the period of study including five in Group 2, four in Group 3, three in Group 4 and one in Group 5.
The survival time was analyzed with survival curve (Figure 4) . Log rank test showed significant difference in survival time among five groups (p<0.001). In addition, the survival time in control group was dramatically different from that in four treatment groups (p<0.01). These findings suggest different treatments can prolong the survival time, which was the most evident in the Group 5.
Discussion
The p53 includes wild type and mutant type. In more than 50% of liver cancers, mutant p53 is noted In previous studies, it has been demonstrated the transfection and expressions of p53 gene and double suicide genes (TK and CD gene) in cancer cells 14, 15 , which were not described herein.
Currently, intratumor injection and intravenous administration are two important ways for gene therapy.
Zhu et al. 16 reported injection of p53 gene through hepatic artery could achieve protein expression of p53 in cancer cells demonstrated by western blot assay and immunohistochemistry.
This suggests interventional gene therapy is feasible and effective.
In the present study, target genes were administered into liver cancer through hepatic artery which solves the problem of targeted gene transfer. Interventional gene therapy may also reduce the influence on normal hepatocytes and the side effects. In addition, lipiodol embolism may aggravate the hypoxia in the cancer and can exert long-term effect on cancer with the anti-tumor effect of suicide genes. Thus, we speculate that interventional gene therapy may be an ideal strategy for the gene therapy of malignancies. In the present study, on the second day of interventional therapy, prodrugs (GCV and 5-Fc) were administered through the portal venous system for consecutive ten days. Intraperitoneal administration of prodrugs may achieve stable, sustained and high concentration of prodrugs in the abdominal cavity, portal vein and liver.
Conclusions
The 
